A Single-Center, Retrospective Cohort Study Evaluating the Use of Probiotics for the Prevention of Hospital-Onset

antibiotic stewardship antibiotics clostridium difficile infection probiotics

Journal

Hospital pharmacy
ISSN: 0018-5787
Titre abrégé: Hosp Pharm
Pays: United States
ID NLM: 0043175

Informations de publication

Date de publication:
Feb 2023
Historique:
pmc-release: 01 02 2024
entrez: 16 1 2023
pubmed: 17 1 2023
medline: 17 1 2023
Statut: ppublish

Résumé

Exposure to antimicrobials is a known risk factor for To evaluate the rates of hospital-onset Clostridioides difficile infection (HO-CDI) among patients who received intravenous (IV) antibiotics plus probiotics versus IV antibiotics alone. Retrospective, single-center cohort study. We included adult patients that received at least 1 dose of IV antibiotics and had a hospital length of stay of at least 3 days between August 2017 and July 2020. Patients were separated into 2 cohorts, either receipt of probiotics or non-receipt of probiotics. Patients with positive We identified 17 598 patients that received IV antibiotics alone and 2659 patients received IV antibiotics plus probiotics. HO-CDI occurred in 46 (0.26%) of those that received antibiotics alone compared to 5 (0.19%) of those that received probiotics with IV antibiotics (OR 0.72, 95% CI 0.28-1.81). ICU admission (OR 1.81, 95% CI 1.02-3.19) and history of CDI (OR 3.37, 95% CI 1.07-10.97) in the past 12 months were associated with a higher incidence of HO-CDI. The addition of probiotics did not reduce the incidence of HO-CDI among inpatients receiving IV antibiotics.

Sections du résumé

Background UNASSIGNED
Exposure to antimicrobials is a known risk factor for
Objective UNASSIGNED
To evaluate the rates of hospital-onset Clostridioides difficile infection (HO-CDI) among patients who received intravenous (IV) antibiotics plus probiotics versus IV antibiotics alone.
Design UNASSIGNED
Retrospective, single-center cohort study.
Methods UNASSIGNED
We included adult patients that received at least 1 dose of IV antibiotics and had a hospital length of stay of at least 3 days between August 2017 and July 2020. Patients were separated into 2 cohorts, either receipt of probiotics or non-receipt of probiotics. Patients with positive
Results UNASSIGNED
We identified 17 598 patients that received IV antibiotics alone and 2659 patients received IV antibiotics plus probiotics. HO-CDI occurred in 46 (0.26%) of those that received antibiotics alone compared to 5 (0.19%) of those that received probiotics with IV antibiotics (OR 0.72, 95% CI 0.28-1.81). ICU admission (OR 1.81, 95% CI 1.02-3.19) and history of CDI (OR 3.37, 95% CI 1.07-10.97) in the past 12 months were associated with a higher incidence of HO-CDI.
Conclusion UNASSIGNED
The addition of probiotics did not reduce the incidence of HO-CDI among inpatients receiving IV antibiotics.

Identifiants

pubmed: 36644740
doi: 10.1177/00185787221120153
pii: 10.1177_00185787221120153
pmc: PMC9837316
doi:

Types de publication

Journal Article

Langues

eng

Pagination

57-61

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Lancet. 2013 Oct 12;382(9900):1249-57
pubmed: 23932219
Clin Infect Dis. 2018 Jun 1;66(12):1957-1959
pubmed: 29272341
J Hosp Infect. 1998 Sep;40(1):1-15
pubmed: 9777516
CMAJ Open. 2016 Nov 24;4(4):E706-E718
pubmed: 28018885
Clin Microbiol Rev. 2018 Mar 14;31(2):
pubmed: 29540433
Open Forum Infect Dis. 2018 Dec 13;5(12):ofy192
pubmed: 30568976
Cochrane Database Syst Rev. 2017 Dec 19;12:CD006095
pubmed: 29257353
Curr Opin Gastroenterol. 2018 Jan;34(1):3-10
pubmed: 29189354
Clin Infect Dis. 2021 Oct 20;73(8):1330-1337
pubmed: 33972996
J Antimicrob Chemother. 2003 Jun;51(6):1339-50
pubmed: 12746372
Am J Gastroenterol. 2010 Jul;105(7):1636-41
pubmed: 20145608
Am J Gastroenterol. 2021 Jun 1;116(6):1124-1147
pubmed: 34003176
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384
Clin Infect Dis. 2015 May 15;60 Suppl 2:S148-58
pubmed: 25922401
Can Fam Physician. 2005 Nov;51:1455-7, 1462-4
pubmed: 16353824
Front Med (Lausanne). 2018 May 07;5:124
pubmed: 29868585
Clin Microbiol Infect. 2012 Dec;18 Suppl 6:21-7
pubmed: 23121551
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48
pubmed: 29462280
Open Med. 2013 May 28;7(2):e56-67
pubmed: 24348885
Clin Infect Dis. 2008 Jan 15;46 Suppl 1:S43-9
pubmed: 18177221

Auteurs

Punit Jitendra Shah (PJ)

Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.

Hala Halawi (H)

Houston Methodist Hospital, Houston, TX, USA.

Jessica Kay (J)

Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.

Adanma Akogun (A)

Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.

Silvia Wise (S)

Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.

Sarfraz Aly (S)

Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.

Nicolas Daoura (N)

Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA.

David Putney (D)

Houston Methodist Hospital, Houston, TX, USA.

Classifications MeSH